Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session



  • Ambrx Biopharma Inc. AMAM shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
  • ClearOne, Inc. CLRO gained 85% to $1.51 after the company and Shure Incorporated announced they reached a global settlement of all pending legal disputes.
  • Rockley Photonics Holdings Limited RKLY rose 48.3% to $0.4218 after jumping 18% on Thursday. Rockley Photonics, last month, reported worse-than-expected Q3 sales results and issued 2022 revenue guidance below estimates.
  • Marin Software Incorporated MRIN shares climbed 34.5% to $1.52. Marin Software joined the Walmart Platform Partner program as an API partner.
  • UpHealth, Inc. UPH shares climbed 30.6% to $3.06. Healthcare transformation expert Timothy Wilde joined UpHealth as Chief Technology Officer.
  • China Jo-Jo Drugstores, Inc. CJJD gained 29.4% to $2.7953.
  • Hello Group Inc. MOMO jumped 29% to $8.77. Morgan Stanley upgraded Hello Group from Equal-Weight to Overweight and raised the price target from $5 to $9.
  • Arcellx, Inc. ACLX gained 27.8% to $27.71. Kite, a Gilead Sciences Inc company, announced a global strategic collaboration to co-develop and co-commercialize Arcellx’s lead late-stage product candidate, CART-ddBCMA, for relapsed or refractory multiple myeloma. Arcellx also announced interim CART-ddBCMA Phase 1 results (October 31, 2022 cutoff date), demonstrating deep and durable responses.
  • Baudax Bio, Inc. BXRX shares gained 23% to $5.01 after the company announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery.
  • Daktronics, Inc. DAKT jumped 23% to $2.1518. Daktronics delayed its earnings release to address the determination that there is 'substantial doubt' over its ability to continue as a going concern.
  • Acer Therapeutics Inc. ACER gained 21% to $1.90. Acer Therapeutics recently reported a $1.5 million private placement.
  • HUYA Inc. HUYA rose 20.6% to $3.39.
  • NeuroBo Pharmaceuticals, Inc. NRBO shares rose 20.4% to $2.0907 after gaining 25% on Thursday. Ladenburg Thalmann recently initiated coverage on NeuroBo Pharmaceuticals with a Buy rating and announced a price target of $6.
  • Ensysce Biosciences, Inc. ENSC gained 19.2% to $1.1799.
  • SpringBig Holdings, Inc. SBIG jumped 18.4% to $0.7578.
  • Powerbridge Technologies Co., Ltd. PBTS rose 18.3% to $0.1341. Powerbridge Technologies, last month, announced the strategic acquisition of DTI Group.
  • Domo, Inc. DOMO gained 17.7% to $17.53 following better-than-expected Q3 results.
  • Armata Pharmaceuticals, Inc. ARMP jumped 17.7% to $2.26.
  • Phreesia, Inc. PHR rose 16.4% to $31.08 after the company posted upbeat Q3 sales and raised FY23 revenue guidance.
  • Braemar Hotels & Resorts Inc. BHR gained 16.2% to $4.01. Braemar Hotels & Resorts announced an increase in quarterly dividend from $0.01 per share to $0.05 per share and authorized $25 million for share repurchases.
  • DocuSign, Inc. DOCU rose 15.8% to $50.68 after the company reported better-than-expected financial results for its third quarter and issued strong guidance. Piper Sandler upgraded the stock from Underweight to Neutral and lowered the price target from $54 to $50.
  • iClick Interactive Asia Group Limited ICLK gained 14.9% to $4.0901.
  • Johnson Outdoors Inc. JOUT jumped 12.8% to $64.83 following better-than-expected quarterly results.
  • Ikena Oncology, Inc. IKNA gained 12.7% to $3.09.
  • Harpoon Therapeutics, Inc. HARP jumped 11.8% to $1.07.
  • Ecoark Holdings, Inc. ZEST gained 9.3% to $0.59.
  • WaveDancer, Inc. WAVD jumped 9.3% to $0.66.
  • Korea Electric Power Corporation KEP rose 8.9% to $8.07.
  • National Beverage Corp. FIZZ gained 8% to $52.33 following Q2 results.
  • China SXT Pharmaceuticals, Inc. SXTC rose 8% to $0.5199 after dropping 13% on Thursday.
  • Broadcom Inc. AVGO gained 3.7% to $550.93 as the company reported better-than-expected results for its fourth quarter and issued strong sales forecast for the current quarter. Broadcom also raised the quarterly dividend by 12% to $4.60 per share.



  • Getaround Inc. GETR shares tumbled 64.8% to $3.10. Getaround reported closing of business combination with InterPrivate II Acquisition Corp.
  • Grom Social Enterprises, Inc. GROM dipped 58% to $1.6195. Grom Social Enterprises priced $5 million public offering of 1,415,682 units at a price of $2.89 per unit
  • Autolus Therapeutics plc AUTL fell 34.9% to $1.9475 after the company announced pricing of a public offering. The company’s Phase 2 pivotal FELIX trial of obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) adult Acute Lymphoblastic Leukemia (ALL) has met its primary endpoint of Overall Remission Rate (ORR).
  • Meta Materials Inc. MMAT dropped 24.6% to $1.3799. Meta Materials recently announced FINRA has processed and announced the corporate action of exchanging META's Series A Preferred shares for shares of common stock of Next Bridge Hydrocarbons on its daily list.
  • My Size, Inc. MYSZ fell 24% to $3.61.
  • Winc, Inc. WBEV dropped 19% to $0.17.
  • Erasca, Inc. ERAS fell 17.6% to $6.03 after the company priced a 15,384,616 share offering at $6.50 per share.
  • BioVie Inc. BIVI dropped 16.9% to $7.56.
  • Flora Growth Corp. FLGC fell 16.8% to $0.37 after the company announced pricing of a $5 million registered direct offering.
  • Sunlands Technology Group STG declined 16.4% to $6.18.
  • Rent the Runway, Inc. RENT fell 15% to $2.0150. Rent The Runway shares jumped 74% on Thursday after the company reported better-than-expected Q3 sales results.
  • Bluejay Diagnostics, Inc. BJDX declined 15% to $0.45.
  • Save Foods, Inc. SVFD dipped 14.3% to $0.8999.
  • Pharvaris N.V. PHVS shares fell 14.2% to $9.83. Pharvaris shares jumped 339% on Thursday after the company reported top-line Phase 2 data from the RAPIDe-1 study of PHVS416 for the on-demand treatment of HAE attacks.
  • SHF Holdings, Inc. SHFS dropped 13.6% to $3.4995.
  • Sono Group N.V. SEV fell 13.2% to $0.9632. Sono Group shares dropped 5% on Thursday after the company reported worse-than-expected Q3 EPS results.
  • Torrid Holdings Inc. CURV declined 13.1% to $3.7099 after the company reported worse-than-expected Q3 EPS and sales results and issued Q4 2022 and FY22 revenue guidance below estimates.
  • Tivic Health Systems, Inc. TIVC dropped 12.3% to $0.9550. Tivic Health and Reliefband Technologies, LLC terminated acquisition agreement.
  • Lululemon Athletica Inc. LULU fell 12.3% to $328.35. Lululemon posted upbeat results for its third quarter, but issued weak holiday-quarter guidance.
  • Party City Holdco Inc. PRTY fell 12.1% to $0.5210.
  • TransCode Therapeutics, Inc. RNAZ shares fell 11.3% to $0.6441after declining over 25% on Thursday. TransCode Therapeutics recently announced withdrawal of the Registration Statement on Form S-1 filed on November 28, 2022 for a share offering for up to 12.5 million.

Also check this out Bitcoin Tops This Key Level; The Graph Emerges As Top Gainer

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasApparel, Accessories & Luxury GoodsConsumer DiscretionaryMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!